European Deep Value Dividend Portfolio, Series 28
Ticker Symbol: FQAVLX
30 Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
FINLAND (6.68%) |
FORTUM FH |
Fortum Oyj |
3.34% |
$19.68 |
VALMT FH |
Valmet Oyj |
3.34% |
23.91 |
FRANCE (9.99%) |
PUB FP |
Publicis Groupe |
3.34% |
36.49 |
SAN FP |
Sanofi |
3.32% |
95.64 |
HO FP |
Thales S.A. |
3.33% |
69.24 |
GERMANY (13.34%) |
ALV GY |
Allianz SE |
3.33% |
184.98 |
FRE GY |
Fresenius SE & Co. KGaA |
3.34% |
39.44 |
PAH3 GY |
Porsche Automobil Holding SE |
3.34% |
56.17 |
VOW3 GY |
Volkswagen AG (Preference Shares) |
3.33% |
155.86 |
IRELAND (10.01%) |
CRH LN |
CRH Plc |
3.34% |
35.25 |
GLB LN |
Glanbia Plc |
3.33% |
9.55 |
SKG LN |
Smurfit Kappa Group Plc |
3.34% |
38.74 |
ITALY (3.33%) |
IG IM |
Italgas SpA |
3.33% |
5.95 |
THE NETHERLANDS (13.32%) |
ASRNL NA |
ASR Nederland N.V. |
3.32% |
31.72 |
AD NA |
Koninklijke Ahold Delhaize N.V. |
3.33% |
28.35 |
NN NA |
NN Group N.V. |
3.34% |
36.75 |
SBMO NA |
SBM Offshore N.V. |
3.33% |
16.92 |
SPAIN (3.33%) |
CABK SM |
CaixaBank, S.A. |
3.33% |
1.91 |
SWEDEN (10.02%) |
BOL SS |
Boliden AB |
3.34% |
28.44 |
LUNE SS |
Lundin Energy AB |
3.34% |
19.84 |
SKAB SS |
Skanska AB |
3.34% |
19.67 |
SWITZERLAND (3.32%): |
ROG SW |
Roche Holding AG |
3.32% |
331.33 |
UNITED KINGDOM (26.66%) |
AAL LN |
Anglo American Plc |
3.33% |
24.70 |
AV/ LN |
Aviva Plc |
3.33% |
3.49 |
BWY LN |
Bellway Plc |
3.33% |
30.24 |
GSK LN |
GlaxoSmithKline Plc |
3.33% |
17.76 |
IMI LN |
IMI Plc |
3.33% |
13.91 |
MNDI LN |
Mondi Plc |
3.34% |
20.00 |
PSN LN |
Persimmon Plc |
3.34% |
31.04 |
TATE LN |
Tate & Lyle Plc |
3.33% |
8.22 |
*As of the close of business on 10/27/20.
Market values are for reference only and are not indicative of your
individual cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
10/28/2020 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
10/28/2022 |
Historical 12-Month Distribution Rate of Trust Holdings:* |
2.70% |
Historical 12-Month Distribution Per Unit:* |
$0.2700 |
Cash CUSIP |
30315U787 |
Reinvestment CUSIP |
30315U795 |
Fee Accounts Cash CUSIP |
30315U803 |
Fee Accounts Reinvestment CUSIP |
30315U811 |
*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions
in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of
the securities included in the trust are for illustrative purposes only and are not indicative of the trust’s
distribution or distribution rate. Due to the negative economic impact across many industries caused
by the recent COVID-19 outbreak, certain issuers of the securities included in the trust may
elect to reduce the amount of dividends and/or distributions paid in the future. As a result, the
“Historical 12-Month Distribution Rate of Trust Holdings,” which is based on the trailing twelve-month
distributions paid by the securities included in a trust, will likely be higher, and in some
cases significantly higher, than the actual distribution rate achieved by the trust. The historical
12-month distribution per unit is based on the weighted average of the trailing 12-month distributions paid
by the securities included in the portfolio. The historical 12-month distribution rate is calculated by dividing
the historical 12-month distributions by the trust’s offering price. The historical 12-month distribution and
rate are reduced to account for the effects of fees and expenses, which will be incurred when investing in a
trust. Certain of the issuers may have reduced their dividends or distributions over the prior 12 months. The
distribution per unit and rate paid by the trust may be higher or lower than the amount shown above due
to certain factors that may include, but are not limited to, a change in the dividends or distributions paid by
issuers, actual expenses incurred, or the sale of securities in the portfolio.
Sales Charges (based on a $10 public offering
price) |
Standard Accounts |
Transactional Sales Charges: |
Initial: |
0.00% |
|
Deferred: |
2.25% |
Creation & Development Fee: |
|
0.50% |
Maximum Sales Charge: |
|
2.75% |
Fee/Wrap Accounts |
Maximum Sales Charge: |
|
0.50% |
The deferred sales charge will be deducted in three monthly installments commencing
2/19/21.
When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If
the price exceeds $10.00 per unit, you will pay an initial sales charge.
The maximum sales charge for investors in fee accounts consists of the creation and development fee.
Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges
apply to units purchased as an ineligible asset.
The creation and development fee is a charge of $0.050 per unit collected at the end of the initial offering
period. If the price you pay exceeds $10.00 per unit, the creation and development fee will be less than 0.50%;
if the price you pay is less than $10.00 per unit, the creation and development fee will exceed 0.50%.
In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.
You should consider the portfolio's investment objective, risks, and charges and expenses carefully before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.
Risk Considerations
An
investment in this unmanaged unit
investment trust should be made with an
understanding of the risks involved with
owning common stocks, such as an
economic recession and the possible
deterioration of either the financial
condition of the issuers of the equity
securities or the general condition of the
stock market.
Because the portfolio is concentrated in companies headquartered in Europe and the United Kingdom, it may
present more risks than a portfolio which is broadly diversified over several regions.
An investment in a portfolio containing
equity securities of foreign issuers is subject
to additional risks, including currency
fluctuations, political risks, withholding,
the lack of adequate financial information,
and exchange control restrictions
impacting foreign issuers.
On January 31, 2020, the United Kingdom officially departed the European Union (commonly referred to as
“Brexit”). Brexit has led to volatility in global financial markets, in particular those of the United Kingdom
and across Europe, and may also lead to weakening in political, regulatory, consumer, corporate and financial
confidence in the United Kingdom and Europe.
An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and
certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products,
financial resources, management inexperience and less publicly available information.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational
risks through breaches in cybersecurity.
The recent outbreak of a respiratory disease designated as COVID-19 was first detected in China in December 2019. The global economic impact of the COVID-19 outbreak is impossible to predict but is expected to disrupt
manufacturing, supply chains and sales in affected areas and negatively impact global economic growth prospects. The COVID-19 outbreak has also caused significant volatility and declines in global financial markets, which
have caused losses for investors. The impact of the COVID-19 outbreak may be short term or may last for an extended period of time, and in either case could result in a substantial economic downturn or recession.
The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.
This UIT is a buy and hold strategy and
investors should consider their ability to
hold the trust until maturity. There may be
tax consequences unless units are
purchased in an IRA or other qualified plan.